Philips North America has been the subject of 355 FDA enforcement/approval records tracked by Argus HQ, compared to 2 for Regeneron Pharmaceuticals Inc.
Philips North America: 0 warning letters, 355 recalls, 0 approval records, 0 Form 483s.
Regeneron Pharmaceuticals Inc: 0 warning letters, 2 recalls, 0 approval records, 0 Form 483s.
Side by side
Philips North America — Warning letters0
Regeneron Pharmaceuticals Inc — Warning letters0
Philips North America — Recalls355
Regeneron Pharmaceuticals Inc — Recalls2
Philips North America — Approval records0
Regeneron Pharmaceuticals Inc — Approval records0
Philips North America — Form 483s0
Regeneron Pharmaceuticals Inc — Form 483s0
Timeline
Cite this comparison
Pre-formatted for a story, footnote, or reference list:
"Philips North America vs Regeneron Pharmaceuticals Inc: FDA Enforcement Comparison." Argus HQ, accessed July 17, 2026. https://argushq.ai/compare/philips-north-america-vs-regeneron-pharmaceuticals-inc
Source: FDA.gov (aggregated across Warning Letters, Recalls, Approvals, Form 483s) ↗